About
GlycoTreat develops allergen immunotherapy treatments that manipulate specific glycan structures to modulate the immune system and induce immune tolerance for allergic diseases.
Explore GlycoTreat's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.